Lung Cancer
Conditions
Keywords
lung cancer, cancer screening, health informatics
Brief summary
Adherence to annual follow up is critical to achieving mortality benefits and optimizing cost-effectiveness of lung cancer screening (LCS). However, adherence to LCS follow-up in the real world is suboptimal. Using telehealth, the investigators will co-create Tele-Navigation of Lung Cancer Screening with patients and LCS stakeholders as an intervention to promote adherence of follow-up LCS. The investigators will then implement the Tele-Navi LCS intervention to a pilot sample of patients and evaluate its feasibility in the primary care setting. The investigators will measure the number of patient participants who completed Tele-Navi LCS and follow-up LCS within 180 days from Tele-Navi LCS.
Interventions
BEHAVIORALTele-Navi LCS
Tele-Navi of LCS includes: telehealth coaching from a Tele-Navigator for patients undergoing LCS using a video or telephone call
Sponsors
Wake Forest University Health Sciences
National Institutes of Health (NIH)
National Cancer Institute (NCI)
University of Massachusetts, Worcester
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
50 Years to 77 Years
Healthy volunteers
No
Inclusion criteria
* Is eligible for LDCT for LCS follow-up * Has technology to complete study activities (e.g., video call visit) * English speaker * Has undergone LCS at UMMH * Is overdue for LDCT follow-up
Exclusion criteria
* Has previous diagnosis of lung cancer * Has active cancer diagnosis * Is a nursing home or group care resident * Is pregnant
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Completion of Tele-Navi LCS | 30 days | Number of participants completed Tele-Navi LCS, |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Completion of Follow-up LCS | 180 days | Number of participants who received a low-dose CT (LDCT) for LCS follow-up |
Countries
United States
Participant flow
Pre-assignment details
Of 22 enrolled participants, 2 withdrew prior to the baseline survey.
Participants by arm
| Arm | Count |
|---|---|
| Tele-Navi LCS Tele-Navi of LCS includes telehealth coaching from a Tele-Navigator for patients undergoing LCS using a video or telephone call | 20 |
| Total | 20 |
Baseline characteristics
| Characteristic | Tele-Navi LCS |
|---|---|
| Age, Continuous | 60.5 years |
| Ethnicity (NIH/OMB) Hispanic or Latino | 4 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 16 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 0 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants |
| Race (NIH/OMB) Asian | 0 Participants |
| Race (NIH/OMB) Black or African American | 0 Participants |
| Race (NIH/OMB) More than one race | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 1 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 2 Participants |
| Race (NIH/OMB) White | 17 Participants |
| Region of Enrollment United States | 20 participants |
| Sex: Female, Male Female | 12 Participants |
| Sex: Female, Male Male | 8 Participants |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | 0 / 20 |
| other Total, other adverse events | 0 / 20 |
| serious Total, serious adverse events | 0 / 20 |
Outcome results
Primary
Completion of Tele-Navi LCS
Number of participants completed Tele-Navi LCS,
Time frame: 30 days
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Tele-Navi LCS | Completion of Tele-Navi LCS | 20 Participants |
Secondary
Completion of Follow-up LCS
Number of participants who received a low-dose CT (LDCT) for LCS follow-up
Time frame: 180 days
Population: 2 participants moved out from the healthcare system
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Tele-Navi LCS | Completion of Follow-up LCS | 10 Participants |